News
DGAP-News: 1&1 AG: GfTD builds antenna sites for the 1&1 mobile network
Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Guideline and Proposed Medicare Local Coverage Determination
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”, the “Company”), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ)
Agilent Joins AMBIC to Advance Biomanufacturing
Agilent Technologies Inc. (NYSE: A) announced today that it has become a member of the Advanced Mammalian Biomanufacturing Innovation Center (AMBIC). Joining AMBIC demonstrates the company’s
Tokens.com Reports 2021 Financial Results
Tokens.com Corp. (NEO Exchange Canada: COIN)(Frankfurt Stock Exchange: 76M) (OTCQB US: SMURF) (“Tokens.com” or the “Company”), a publicly-traded company that invests in Web3 crypto assets and
UiPath Announces Reboot Work Festival 2022 Featuring Keynotes and Customer Presentations on the Future of Automation
UiPath (NYSE: PATH), a leading enterprise automation software company, today announced its global Reboot Work Festival—a celebration of automation and a forum of new ideas—will take place virtually
Xylem To Release First Quarter 2022 Financial Results On May 4, 2022
Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, will release its first quarter 2022 results at 6:55 a.m. (ET) on
DGAP-News: cyan AG: cyan's MVNO-platform (BSS/OSS) chosen by LIWA to expand the digital portfolio to include mobile connectivity
Newmont Announces First Quarter 2022 Earnings Call
Newmont Corporation (NYSE: NEM, TSX: NGT) today announced it will report first quarter 2022 operations and financial results before the market opens on Friday, April 22, 2022, and will hold a
Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
DGAP-Adhoc: Südzucker executive board proposes a dividend of 0.40 euro per share for fiscal 2021/22
IMV Inc. to Present at Two Upcoming Investor Conferences
IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and hematologic cancers, today
NICE Actimize Named Best Suitability Product by the WealthBriefing European Awards 2022
NICE Actimize, a NICE (NASDAQ: NICE) business, was awarded the Best Suitability Product by WealthBriefing European Awards 2022 for its SURVEIL-X Suitability for Wealth and Insurance solution
Fluor Announces Japan Bank for International Cooperation Investment of $110 Million Into NuScale Power
Fluor Corporation (NYSE: FLR) announced today that Japan Bank for International Cooperation (JBIC), through Japan NuScale Innovation, LLC, a special purpose investment entity that also includes JGC
Perion Expects $22M in Adjusted EBITDA For the First Quarter of 2022, More Than Double Q1/2021
Perion Network Ltd. (NASDAQ: PERI), a global advertising technology company that delivers holistic solutions across the three main pillars of digital advertising – ad search, social media and
CURO Expands Canada SPV Facility with Additional C$50 Million in Committed Capacity
CURO Group Holdings Corp. (NYSE: CURO) (“CURO”), a tech-enabled, omni-channel consumer finance company serving a full spectrum of non-prime and prime consumers in the U.S. and Canada, today
DGAP-News: Krones AG: Krones increases prices for new machines and lines
Starbucks Founder Howard Schultz Takes the Helm as Starbucks Chief Executive Officer
Starbucks Corporation (NASDAQ: SBUX) today marked the return of founder Howard Schultz as chief executive officer and as a director on the company’s Board.
In an early morning letter, Schultz
DGAP-News: Rubean AG: Sparkassen-Finanzgruppe launches expanded Rubean app on the market
Technip Energies to Provide FEED for Equinor Floating Offshore Wind Firefly Project in South Korea
Technip Energies (PARIS:TE) has been selected by Equinor South Korea Co Ltd to perform a Front-End Engineering Design (FEED) for the offshore floating wind Firefly project, located 70 kilometers
DIAMOND trial: Veltassa® enables patients to achieve long-term potassium control and optimized RAASi therapy
Regulatory News:
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR
Vifor Pharma today announced full results from its phase-IIIb DIAMOND trial showing that Veltassa® allowed patients to achieve
Nordea Bank Abp: Transaction in Own Shares
Edison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
DGAP-News: Delivery Hero announces launch of EUR 1.4 billion-equivalent debt financing syndication and issues outlook to reach positive adjusted EBITDA on a group level in 2023
DGAP-Adhoc: Delivery Hero SE announces launch of EUR 1.4 billion-equivalent debt financing syndication and issues outlook to reach positive adjusted EBITDA on a group level in 2023
Silence Therapeutics Announces Detailed Results From SLN360 Phase 1 Study in High Lipoprotein(a) Presented in Late Breaker at the American College of Cardiology (ACC.22) Annual Meeting
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA) therapeutics for the